# Central IRB Services for NIAID Coronavirus COVID-19 OWS ACTIV-3 Clinical Trial

> **NIH NIH N02** · MEDICAL SCIENCE & COMPUTING, LLC · 2020 · $718,961

## Abstract

The purpose of this funding is to provide the Central Institutional Review Board (IRB) services for the Coronavirus COVID-19 ACTIV-3 trial.

## Key facts

- **NIH application ID:** 10274221
- **Project number:** 272201500015I-0-759302000017-3
- **Recipient organization:** MEDICAL SCIENCE & COMPUTING, LLC
- **Principal Investigator:** ANNA MAHYERA
- **Activity code:** N02 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $718,961
- **Award type:** —
- **Project period:** 2020-03-30 → 2021-03-29

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10274221

## Citation

> US National Institutes of Health, RePORTER application 10274221, Central IRB Services for NIAID Coronavirus COVID-19 OWS ACTIV-3 Clinical Trial (272201500015I-0-759302000017-3). Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/grant/nih/10274221. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*